6
Disclosures
Feb 13, 2026 — May 26, 2026
Date Range
PRIME
Market Segment
Chemicals
Sector

Disclosures

DateTypeHeadlinePDF
May 26 Other Takasago International Amends Financial Report Due to Capital Structure Error PDF
Apr 28 Other Takasago International Enhances Board Effectiveness Through Evaluation PDF
Feb 24 Forecast Takasago International Completes Sale of Koshu Pharmaceutical Shares for 1.489 Billion PDF
Feb 13 Other TAKASAGO INTERNATIONAL REPORTS Q3 LOSS, LOWER GUIDANCE; TO PAY MIDDLE DIVIDEND OF 120 PER SHARE PDF
Feb 13 Forecast Earnings Forecast Downward Revision PDF
Feb 13 Earnings TAKASAGO INTERNATIONAL CORPORATION Reports Q3 FY2026 Earnings Presentation: Revenue of 93.4 billion PDF

Disclosure Types

Other: 3 Forecast: 2 Earnings: 1